Pharmafile Logo
Pharmafocus logo
Advanced Search

gene therapy

Showing 15 posts of 44 posts found.

Roche set to acquire Spark Therapeutics in $4.8 billion deal

February 25, 2019
Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma

Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards …

News
janssen_latest_logo_on_sign_closer

Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019
Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …

News
zeiss_microscopy

Scientists prevent axon self-destruct mechanism using gene therapy

January 17, 2019
Research and Development Axon, gene therapy, health, neuropathy

Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) …

News
16792957331_d9572dbdf4_z

US regulator to recruit 50 new gene and cell therapy clinical reviewers

January 16, 2019
Research and Development FDA, cell therapy, gene therapy, regulation

FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …

News
lilly_building_with_american_flag_web

Eli Lilly to buy Loxo Oncology in deal worth $8 billion

January 7, 2019
Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine

US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …

News
gehrynovartis

Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …

News

Astellas acquires gene therapy group Quethera in £85 million deal

August 13, 2018
Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision

The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …

News
ki67-tubulin-2

Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics

July 20, 2018
Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn

The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …

News

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018
Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …

News

Spark gains approval for gene therapy, paving way for first $1m treatment

December 20, 2017
Research and Development, Sales and Marketing Spark Therapeutics, biotech, drugs, gene therapy, pharma, pharmaceutical

The FDA handed approval to Spark Therapeutics’ gene therapy for an inherited eye disorder, making it the first treatment of …

News
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017
Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …

News
genes

Gene therapy: Advanced treatments for a new era

March 3, 2017
Medical Communications gene therapy

Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …

News
pfizer_credit_flickr__ceiling

Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics

August 2, 2016
Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy

Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …

News
blue_jeans

Strong early data on haemophilia gene therapy boosts Biomarin

July 28, 2016
Medical Communications, Research and Development BioMarin, gene therapy, haemophilia a

Biomarin has presented interim results from a Phase I/II study that is being hailed as positive “proof-of-concept” data for their …

News
gsk_l_rgb

GSK’s gene therapy Strimvelis gets European regulatory nod

June 1, 2016
Research and Development, Sales and Marketing EU, European Commission, GlaxoSmithKline, Strimvelis, gene therapy, regulation

UK drugmaker GlaxoSmithKline (LSE: GSK) said its gene therapy Strimvelis has secured backing from the European regulators. The European Commission …

News

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024